Panot Capital will manage an extensive real estate portfolio on behalf of a series of trusts; will expand real estate investments and client relationships nationwide
HOUSTON, April 03, 2024–(BUSINESS WIRE)–Real estate executives Aaron Iskowitz and Zain Sayed have recently established Panot Capital, a dedicated real estate investment management firm based in Houston with offices in California, New York, Ohio and Rhode Island.
Panot Capital, established in late 2023, was formed to manage an extensive real estate portfolio on behalf of a series of trusts. The firm has plans to expand its investments and client relationships nationwide, focusing on real estate investment management and development.
Panot Capital was formed to create a data-driven institutional-quality investment framework for the management of a family-owned portfolio that develops and owns real estate projects with a focus on multi-family and mixed-use communities. Panot Capital manages properties in 13 cities in eight states, overseeing portfolio management, acquisitions, asset management, and development activities.
About Aaron Iskowitz
Aaron Iskowitz was previously the chief operating officer at Urban Smart Growth (USG), a real estate development and management company. During his decade-long tenure at the company, he managed all of USG’s operations nationwide.
Before joining USG in 2013, Iskowitz was vice president in the capital markets group at Avison Young, a senior associate at The Carlton Group and a project manager / financial analyst at New Jersey-based regional real estate developer Woodmont Properties.
Iskowitz graduated from Union College with a BA in Managerial Economics. He also received an MS in Real Estate, with a concentration in Finance, along with an advanced degree in Cities and Urban Development, from New York University.
About Zain Sayed
Zain Sayed brings deep experience in investing and managing institutional commercial real estate capital. Previously, Sayed served as the Head of Portfolio and Asset Management at Parkway Properties overseeing a $3 billion national office and mixed-use portfolio involving asset performance, investment strategy, recapitalizations, and dispositions. In addition, Sayed managed the development of data-driven investment strategies to enhance investment decisions and asset-level execution.
Prior to Parkway Properties, Sayed was the U.S. West Head of Asset Management at Lionstone Investments overseeing all asset management operations for nearly $6 billion in value-add and core assets located in Texas, Colorado, Washington, Oregon and California.
Sayed was previously an asset manager at MetLife Investment Management, managing over $3.1 billion in joint venture real estate assets. Prior to asset management, he was responsible for the credit risk portfolio management and valuation review for over $20 billion in mortgages within MetLife’s commercial mortgage portfolio.
Sayed holds a M.S. degree in Real Estate from New York University, a M.S. degree in Data Science from Northwestern University, and a B.A. in Economics from Georgetown University.
Sayed is currently a member of the Urban Land Institute and sits on the Technology and Real Estate Council (TREC).
View source version on businesswire.com: https://www.businesswire.com/news/home/20240403244198/en/
Contacts
TORONTO, Feb. 22, 2024 /CNW/ – Prerna Mathews, VP, ETF Product Strategy, Mackenzie Investments, and her team joined Keith Wu, Head, Exchange Traded Products & TMX Market Center, Toronto Stock Exchange (TSX), to open the market and celebrate the launch of the Mackenzie World Low Volatility ETF (TSX: MWLV).
Mackenzie Investments (“Mackenzie”) is a leading investment management firm with $195.7 billion in assets under management as of December 31, 2023. Mackenzie provides investment solutions and related services to more than one million retail and institutional clients through multiple distribution channels. Founded in 1967, Mackenzie is a global asset manager with offices across Canada as well as in Boston, Dublin, London, Hong Kong and Beijing. Mackenzie is a member of IGM Financial Inc. (TSX: IGM), one of Canada’s premier financial services companies with approximately $240 billion in total assets under management as of December 31, 2023. For more information, visit mackenzieinvestments.com.
CNW sponsored announcement. To learn more visit www.newswire.ca.
View original content to download multimedia:https://www.prnewswire.com/news-releases/mackenzie-investments-opens-the-market-302068983.html
SOURCE Toronto Stock Exchange
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2024/22/c6442.html
Introduction to the Transaction
Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently made a significant adjustment to its holdings in Staar Surgical Co (NASDAQ:STAA). On December 1, 2023, the firm reduced its position in the company, signaling a strategic shift in its investment portfolio. This move by Baillie Gifford (Trades, Portfolio) has caught the attention of investors and market analysts alike, as it reflects the firm’s ongoing portfolio management decisions.
Baillie Gifford (Trades, Portfolio)’s Profile
With over a century of experience, Baillie Gifford (Trades, Portfolio) stands as a testament to investment excellence and client-focused strategies. The firm’s dedication to fundamental analysis and proprietary research underpins its long-term, bottom-up investment approach. Baillie Gifford (Trades, Portfolio)’s portfolio is a reflection of its commitment to identifying companies with sustainable growth potential, a philosophy that has been the cornerstone of its success for more than 100 years.
Details of the Trade Action
The transaction in question occurred on December 1, 2023, when Baillie Gifford (Trades, Portfolio) decided to reduce its stake in Staar Surgical Co. The firm sold 469,918 shares, resulting in a 9.55% decrease in its position. This reduction had a minor impact of -0.01% on Baillie Gifford (Trades, Portfolio)’s overall equity, with the trade executed at a price of $32.99 per share.
Impact on Baillie Gifford (Trades, Portfolio)’s Portfolio
Following the transaction, Baillie Gifford (Trades, Portfolio) holds 4,448,208 shares of Staar Surgical Co, which represents a 0.13% position in the firm’s portfolio and a 9.11% stake in the company. This adjustment reflects Baillie Gifford (Trades, Portfolio)’s strategic portfolio realignment and its ongoing assessment of investment opportunities.
Staar Surgical Co’s Stock Information
Staar Surgical Co, a USA-based medical device manufacturer, specializes in lenses for eye surgeries, including those for cataract and refractive surgeries. Since its IPO on July 7, 1983, the company has shown significant growth. With a market capitalization of $1.44 billion and a stock price of $29.58, Staar Surgical Co operates within the competitive Medical Devices & Instruments industry. Despite its current PE Ratio of 75.85, the company’s stock is considered a possible value trap by GuruFocus, urging investors to think twice before investing.
Market Context and Analysis
Staar Surgical Co’s market capitalization and stock price have experienced fluctuations, with a current stock price representing a 10.34% decrease since the trade date. The company’s stock has grown 886% since its IPO, but the year-to-date performance shows a slight decline of 0.5%. GuruFocus ranks the company’s financial health and growth prospects with a GF Score of 72/100, indicating potential for average performance.
Other Notable Investors in Staar Surgical Co
While Baillie Gifford (Trades, Portfolio) has adjusted its holdings, other notable investors maintain positions in Staar Surgical Co. Ken Fisher (Trades, Portfolio) is among the gurus who also hold shares in the company, highlighting the interest from various investment management entities.
Conclusion
The recent trade by Baillie Gifford (Trades, Portfolio) in Staar Surgical Co reflects a strategic decision by the firm to realign its investment portfolio. Despite the reduction, Staar Surgical Co remains a part of Baillie Gifford (Trades, Portfolio)’s diverse holdings, with the company’s future outlook and market standing continuing to be monitored by the investment community. Investors and analysts will be watching closely to see how this transaction influences both Baillie Gifford (Trades, Portfolio)’s portfolio and the performance of Staar Surgical Co’s stock in the market.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.